Browse studies

Find your next paid study

4 recruiting studies matching your filters

Open-label, Long-term Safety and Efficacy Study of Mim8 in Participants With Haemophilia A With or Without Inhibitors

This study is looking at how Mim8 works in people with haemophilia A, who either have inhibitors or do not have inhibitors. Mim8 is a new medicine that will be…

Haemophilia AHaemophilia A With Inhibitors

Estimated

~$10 – $7,500

Novo Nordisk A/SNCT05685238

Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated & Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment With Nuwiq, Octanate or Wilate - Efficacy & Safety Observational Study-Protect-NOW

International, post-authorisation non-interventional study to evaluate real-life effectiveness, safety and utilisation patterns of Octapharma's FVIII concentra…

Haemophilia A

Estimated

~$10 – $1,050

OctapharmaNCT03695978

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Peroral Doses of Inno8 in People With Haemophilia A

This study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8…

Haemophilia A

Estimated

~$10 – $7,500

Novo Nordisk A/SNCT07220564

Phase 1

A Single-centre, Open-label, Randomised, Single-dose Study to Evaluate the Effect of Pre- and Post-dose Meal Timings on the Pharmacokinetic Properties of Inno8 in Healthy Participants

The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it…

Haemophilia A

Estimated

~$10 – $7,500

Novo Nordisk A/SNCT07238816